Measurement and treatment of elevated blood pressure in the pediatric patient with chronic kidney disease

Advances in Chronic Kidney Disease

Volumn 11, Issue 2, 2004, Pages 143-161

  Swinford, Rita D ^a   Portman, Ronald J ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

ambulatory blood pressure monitoring; chronic kidney disease; end organ damage; Hypertension; pediatric

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BISOPROLOL; CANDESARTAN; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ESMOLOL; FELODIPINE; FENOLDOPAM; FOSINOPRIL; IRBESARTAN; LABETALOL; LISINOPRIL; METOPROLOL; MINOXIDIL; MOEXIPRIL; QUINAPRIL; RAMIPRIL; TIMOLOL; VALSARTAN; VERAPAMIL;

AUSCULTATION; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL; CALIBRATION; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COMORBIDITY; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EVALUATION; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERTENSION; NERVOUS SYSTEM; ORGAN INJURY; OSCILLOMETRY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIDE EFFECT; SLEEP; UNITED STATES; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CHILD; CHRONIC KIDNEY FAILURE; INSTRUMENTATION; METHODOLOGY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; RENOVASCULAR HYPERTENSION;

BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; CHILD; HUMANS; HYPERTENSION, RENAL; KIDNEY FAILURE, CHRONIC; PRACTICE GUIDELINES; RISK FACTORS;

EID: 4444263341     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.arrt.2004.02.001     Document Type: Article

References (113)

1. Schaefer F., Mehls O. Hypertension in chronic kidney disease. Portman R.P., Sorof J.S., Ingelfinger J.R. Pediatric Hypertension. 2004;Humana Press, Totowa, NJ. (in press)
2. Sharer K. Hypertension in children and adolescents. Malluche H.H., Sawaya B.P., Hakim R.M.,, et al. Clinical Nephrology, Dialysis and Transplantation A Continuously Updated Textbook. 1999;1-28 Dustri-Verlag, Deisenhofen
3. North American Pediatric Renal Transplant Cooperative Study (NAPTRCS) 2003 Annual Report Chronic renal insufficiency exhibit 13.7 baseline. Concomitant Drug Ther. 2003;. 13-10
4. Mitsnefes M., Ho P.-L., McEnery P.T. Hypertension and progression of chronic renal insufficiency in children a report of the North American Pediatric Renal Transplant Cooperative Study (NAPTRCS). J Am Soc Nephrol. 4:2003;2618-2622
5. Sorof J.S. Definitions of hypertension in children. Portman R.P., Sorof J.S., Ingelfinger J.R. Pediatric Hypertension. 2004;Humana Press, Totowa, NJ. (in press)
6. Blumenthal S., Eps R.P., Heavenrich R., et al. Report of the task force on blood pressure control in children. Pediatrics. 59:1977;797-820
7. Task Force on Blood Pressure Control in Children Report of the second task force on blood pressure control in children - 1987. Pediatrics. 79:1987;1-25
8. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: A working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education
9. Gillman M.W., Cook N.R. Blood pressure measurement in childhood epidemiological studies. Circulation. 92:1995;1049-1057
10. Sorof J.M., Alexandrov A.V., Cardwell G., et al. Carotid artery intimal thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics. 111:2003;61-66
11. Sorof J.M., Cardwell G., Franco K., et al. Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension. 39:2002;903-908
12. Daniels S.R., Loggie J.M., Khoury P., et al. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation. 97:1998;1901-1911
13. Sorof J.M., Poffenbarger T., Franco K., et al. Evaluation of white coat hypertension in children Importance of the definitions of normal ambulatory blood pressure and the severity of casual hypertension. Am J Hypertens. 14:2001;855-860
14. Covic A., Goldsmith D.J.A., Georgescu G.C., et al. Relationships between blood pressure variability and left ventricular parameters in hemodialysis and renal transplant patients. Nephrology. 4:1998;87-94
15. Appel L.J., Robinson K.A., Guallar E., et al. Utility of blood pressure monitoring outside of the clinic setting. 2004;. Evidence/Technology Assessment, No 63, U.S. Department of Health and Human Service, Agency for Healthcare Research and Quality. Available at: http://www.ahrq.gov. Accessed March 5
16. Baumgert P., Walger P., Gemen S., et al. Blood pressure elevation during the night in chronic renal failure, hemodialysis and after renal transplantation. Nephron. 57:1991;293-298
17. Middeke M., Schrader J. Nocturnal blood pressure in normotensive subjects and those with white coat, primary, and secondary hypertension. BMJ. 308:1994;630-632
18. Lurbe E., Redon J., Kesani A., et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med. 347:2002;797-805
19. Belsha C.W., Wells T.G., McNiece K.L., et al. Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension. Am J Hypertens. 11:1998;410-417
20. Reiss U., Wingen A.M., Schärer K. Mortality trends in pediatric patients with chronic renal failure. Pediatr Nephrol. 10:1996;602-605
21. Groothof J.W., Gruppen M.P., Offringa M., et al. Mortality and causes of death of end-stage renal disease in children a Dutch cohort study. Kidney Int. 61:2002;621-629
22. Scharer D.K. Hypertension in end-stage renal disease. Portman R.P., Sorof J.S., Ingelfiner J.R. Pediatric Hypertension. 2004;Humana Press, Totowa, NJ. (in press)
23. Arnett D.K., Glasser S.P., McVeigh G., et al. Blood pressure and arterial compliance in young adults The Minnesota Children's Blood Pressure Study. Am J Hyperten. 14:2001;200-205
24. Stanger O., Semmelrock H.J., Wonlsch W., et al. Effects of folate treatment and homocysteine lowering on resistance vessel reactivity in atherosclerotic subjects. JPET. 303:2002;158-162
25. Savage M.T., Ferro C.J., Pinder S.J., et al. Reproducibility of derived central arterial waveforms in patients with chronic renal failure. Clin Sci. 103:2002;59-65
26. London G.M., Cohn J.N. Prognostic application of arterial stiffness Task forces. AJH. 15:2002;754-758
27. Dogra G.K., Watts G.F., Herrmann S., et al. Statin therapy improves brachial artery endothelial function in nephrotic syndrome. Kidney Int. 62:2002;550-557
28. Constantijn J.A.M. Arterial wall properties in patients with renal failure. Am J Kidney Dis. 39:2002;1206-1212
29. Lantelme P. Heart rate An important confounder of pulse wave velocity assessment. Hypertension. 39:2002;1083-1087
30. Kavazurakis E., Moustaki M., Gourigiotis D., et al. The impact of serum lipid levels on circulating soluble adhesion molecules in childhood. Pediatr Res. 52:2002;454-458
31. Bennett-Richards K.J., Kattenhorn M., Donald A.E., et al. Oral L-arginine does not improve endothelial dysfunction in children with chronic renal failure. Kidney Int. 62:2002;1372-1378
32. Kari J.A., Donald A.E., Vallance D.T., et al. Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int. 52:1997;468-472
33. Cavalcanti S., Cavni S., Santor A. Role of short-term regulatory mechanisms on pressure response to hemodialysis-induced hypovolemia. Kidney Int. 61:2002;228-238
34. Cohn J.N. Vascular wall function as a risk marker for cardiovascular disease. J Hypertens. 17:(suppl 5):1999;S41-S44
35. Swinford R.D., Sorof J.S., Poffenbarger T., et al. Abnormal vascular compliance of large and small vessels in adolescent hemodialysis patients. Pediatr Nephrol. 2004;. (in press)
36. Goren A., Glaser I., Drukker A. Diastolic function in children and adolescents on dialysis and after kidney transplantation An echocardiographic assessment. Pediatr Nephrol. 7:1993;725-728
37. Johnstone L.M., Jones C.L., Grigg L.E., et al. Left ventricular abnormalities in children, adolescents and young adults with renal disease. Kidney Int. 50:1996;998-1006
38. Parfrey P.S., Foley R.N., Harnett J.D., et al. Outcome and risk factors for left ventricular disorders in chronic uremia. Nephrol Dial Transplant. 11:1996;1277-1285
39. Middleton R.J., Parfrey P.S., Foley R. Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol. 12:2001;1079-1084
40. Mitsnefes M.M., Daniels S.R., Schwartz S.M., et al. Severe left ventricular hypertrophy in pediatric dialysis Prevalence and predictors. Pediatr Nephrol. 14:2000;898-902
41. Mitsnefes M.M., Schwartz S.M., Daniels S.R., et al. Changes in left ventricular mass index in children and adolescents after renal transplantation. Pediatr Transplant. 5:2001;279-284
42. Middleton R.J., Parfrey P.S., Foley R.N. Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol. 12:2001;1079-1084
43. Raine A.E.G., Schwarz U., Ritz E. Hypertension and cardiac problems. Davidson A.M., Cameron J.S., Grunfeld J.P.,, et al. Oxford Textbook of Clinical Nephrology. (ed 2):1998;1885-1918 Oxford University Press, Oxford, UK
44. Schärer K., Schmidt K.G., Soergel M. Cardiac function and structure in patients with chronic renal failure. Pediatr Nephrol. l3:1999;951-965
45. Morgan H., Khan I., Hashmi A., et al. Ambulatory blood pressure monitoring after renal transplantation in children. Pediatr Nephrol. 16:2001;843-847
46. Washio M., Okuda S., Mizou C.T., et al. Risk factors for left ventricular hypertrophy in chronic hemodialysis patients. Clin Nephrol. 47:1997;362-366
47. London G.M., Pannier B., Guerin A.P., et al. Alterations of left ventricular hypertrophy and survival of patients receiving hemodialysis Follow-up of an interventional study. J Am Soc Nephrol. 12:2001;2759-2767
48. Chan C.F., Floras J.S., Miller J.A., et al. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int. 61:2002;2235-2239
49. Holttä T., Happonen J.M., Rönnholm K., et al. Hypertension, cardiac state, and the role of volume overload during peritoneal dialysis. Pediatr Nephrol. 16:2001;324-331
50. Litwin M., Kawalec W., Grenda R. Left ventricular changes in the course of chronic renal failure and during dialysis therapy. Timio M., Wizemann V., Venanzi S. 6th European Meeting on Cardionephrology. 1997;93-96 Editoriale Bios, Cosenza
51. Sorof J.M., Poffenbarger T., Portman R.J. Abnormal 24-hour blood pressure pattern in children after renal transplantation. Am J Kidney Dis. 35:2000;681-686
52. Obrien E., Beevers G., Lip G.Y., et al. ABC of hypertension: Blood pressure measurement. Part 1 - sphygmomanometry: Factors common to all techniques. BMJ. 322:2001;981-985
53. Morgenstern B.Z., Butani L. Casual blood pressure methodology. Portman R.P., Sorof J.S., Ingelfiner J.R. Pediatric Hypertension. 2004;Humana Press, Totowa, NJ. (in press)
54. Rocchini A.P. Pediatric hypertension 2001. Curr Opin Cardiol. 17:2001;385-389
55. Markandu N.D., Whitcher F. The mercury sphygmomanometer should be abandoned before it is proscribed. J Hum Hypertens. 14:2000;31-36
56. Vanasse A., Courteau J. Evaluation of sphygmomanometers used by family physicians practicing outside the hospital environment in Bas-Saint-Laurent. Can Fam Physician. 47:2001;281-286
57. Mion D., Pierin A.M. How accurate are sphygomanometers? J Hum Hypertens. 12:1998;245-248
58. Perloff D., Grim C., Flack J., et al. Human blood pressure determination by sphygmomanometry. Circulation. 88:1993;2460-2470
59. Park M.K., Menard S.W., Yuan C. Comparison of ausculatatory and oscillometric blood pressures. Arch Pediatr Adolesc Med. 155:2001;50-53
60. National Heart, Lung, and Blood Institute, Bethesda, Maryland Report of the Second Task Force on Blood Pressure Control in Children - 1987. Pediatrics. 79:1987;1-25
61. Colan S.D., Fujii A., Borow K.M., et al. Noninvasive determination of systolic, diastolic and end-systolic blood pressure in neonates, infants and young children comparison with central aortic pressure measurements. Am J Cardiol. 52:1983;867-870
62. Park M.K., Menard S.W., Yuan C. Comparison of auscultatory and oscillometric blood pressures. Arch Pediatr Adolesc Med. 155:2001;50-53
63. Wattigney W.A., Webber L.S., Lawrence M.D., et al. Utility of an automatic instrument for blood pressure measurement in children. The Bogalusa Heart Study. Am J Hypertens. 9:1996;256-262
64. Park M.K., Menard S.M. Normative oscillometric blood pressure values in the first 5 years in an office setting. Am J Dis Child. 143:1989;860-864
65. Rahman M., Griffin V., Kumar A., et al. A comparison of standardized versus "usual" blood pressure measurements in hemodialysis patients. Am J Kidney Dis. 39:2002;1226-1230
66. The 1988 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 148:1988;1023-1038
67. Portman R.J., Yetman R.J., West S.M. Efficacy of 24-hour ambulatory blood pressure monitoring in children. J Pediatr. 118:1991;842-849
68. Soergel M., Kirschstein M., Busch C., et al. Oscillometric twenty-four hour ambulatory blood pressure values in healthy children and adolescents a multi center trial including 114 subjects. J Pediatr. 129:1997;178-184
69. Lurbe E., Redon J. Ambulatory blood pressure methodology and norms in children. Portman R.P., Sorof J.S., Ingelfinger J.R. Pediatric Hypertension. 2004;Humana Press, Totowa, NJ. (in press)
70. Parati G., Ulian L., Santuccio C., et al. Difference between clinic and daytime blood pressure is not a measure of the white coat effect. Hypertension. 31:1998;1185-1189
71. Swinford R.D., Portman R.J. Diagnostic Evaluation of Pediatric Hypertension. Pediatric Nephrology. (ed 5):2004;Lippincott, Williams & Wilkins, Totowa, NJ. (in press)
72. Lingens N., Soergel M., Loirat C., et al. Ambulatory blood pressure monitoring in paediatric patients treated by regular haemodialysis and peritoneal dialysis. Pediatric Nephrol. 9:1995;167-172
73. Sorof J.M., Brewer E.D., Portman R.J. Ambulatory blood pressure monitoring and interdialytic weight gain in children receiving chronic hemodialysis. Am J Kidney Dis. 33:1999;667-674
74. Baluarte H.I., Gruskin A.B., Ingelfiner I.R., et al. Analysis of hypertension in children posttransplantation A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol. 8:1994;570-573
75. Lingens N., Dobos E., Witte K., et al. Twenty-four hour ambulatory blood pressure profiles in pediatric patients after renal transplantation. Pediatr Nephrol. 11:1997;23-26
76. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the Joint National Committee on the Prevention, Detection, Evaluation and Treatment of High Blood Pressure. JAMA. 289:2003;2560-2572
77. Csiky B., Kovacs T., Wagner L., et al. Ambulatory blood pressure and progression in patients with IgA nephropathy. Nephrol Dial Transplant. 14:1999;86-90
78. Timio M., Venanzi S., Lolli S. "Non-dipper" hyper tensive patients and progressive renal insufficiency A 3-year longitudinal study. Clin Nephrol. 43:(6):1995;382-387
79. Farmer K.T., Goldsmith D.J.A., Quin J.D., et al. Progression of diabetic nephropathy - Is diurnal blood pressure rhythm as important as absolute blood pressure level? Nephrol Dial Transplant. 13:1998;635-639
80. Nakano S., Fukuda M., Hotta F., et al. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes. 47:1998;1501-1506
81. McGregor D.O., Olsson C., Kevin L. Autonomic dysfunction and ambulatory blood pressure in renal transplant recipients. Transplantation. 71:2001;1277-1281
82. Tucker B., Fabbian F., Giles M., et al. Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure. Nephrol Dial Transplant. 12:1997;724-728
83. Clement D.L., De Buyzere M.L., Marc L., et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. New Engl J Med. 348:2003;2407-2415
84. Soergel M., Kirschstein M., Busch C., et al. Oscillometric twenty-four hour ambulatory blood pressure values in healthy children and adolescents A multicenter trial including 1141 subjects. J Pediatr. 129:1997;178-184
85. Wḧl E., Witte K., Soergel M., et al. Distribution of 24-h ambulatory blood pressure in children normalized reference values and role of body dimensions. J Hypertens. 20:2002;1995-2007
86. Schaefer F., Klaus G., Ml̈ler-Wiefel D., et al. Current practice of peritoneal dialysis in children results of a longitudinal survey. Perit Dial Int. 19:(suppl):1999;S445-S449
87. Loirat C., Ehrich J.M.H., Geerlings W., et al. Report on management of renal failure in Europe XXII, 1992. Nephrol Dial Transplant. 9:(suppl 1):1994;26-40
88. Lerner G.R., Warady B.A., Sullivan E.K., et al. Chronic dialysis in children and adolescents. The 1996 report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol. 13:1999;404-417
89. Falkner B.E. Treatment of hypertensive children and adolescents. Isso J.L., Black H.R. Hypertension Primer. (ed 3):2003;494-497 Lippincott, Williams, and Wilkins, Philadelphia, PA
90. Portman R.J. Guideline 3, measurement of blood pressure. Kidney Disease Quality Outcome Initiative. Am J Kidney Dis. 2004;. (in press)
91. Lurbe E., Toor I., Paya R., et al. Masked hypertension in adolescents. Am J Hypertens. 16:2003;237A
92. Clement D.L., De Buyzere M.L., De Bacquer D.A., et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 348:2002;2407-2415
93. Lurbe E., Alvarez V., Redon J. Obesity, body fat distribution, and ambulatory blood pressure in children and adolescents. J Clin Hypertens. 3:2001;362-367
94. Loughridge L.W. Renal abnormalities in the Marfan syndrome. Q J Med. 28:1959;531-544
95. Glushien A.S., Mansuy M.M., Littman D.S. Pheaechromocytoma Its relationship to neurocutaneous syndromes. Am J Med. 14:1953;318-327
96. Alpert B.S., Bain H.H., Balfe J.W. Role of the renin-angiotensin- aldosterone system in hypertensive children with coarctation of the aorta. Am J Cardiol. 43:1979;828-831
97. Becker A.E., Becker M.J., Edward J.E. Anomalies associated with coarctation of aorta. Circulation. 41:1979;1067-1069
98. Morriss M., McNamara D. Coarctation of the aorta. Garson A., Bricker J., McNamara D. Science and Practice of Pediatric Cardiology. 1990;1353-1365 Lea & Febiger, Philadelphia, PA
99. Wiggelinkhuizen J., Cremin B.J. Takayasu arateritis and renovascular hypertension in childhood. Pediatrics. 62:1978;209-217
100. Goonasekera C.D.A., Shah V., Wade A.M., et al. The usefulness of renal vein renin studies in hypertensive children A 25-year experience. Pediatr Nephrol. 17:2002;943-949
101. Blowey D.L. Approach to the pharmacologic treatment of pediatric hypertension. Portman J.R., Sorof J.S., Ingelfinger J.R. Pediatric Hypertension. 2004;Humana Press, Totowa, NJ. (in press)
102. Lewis E.J., Hunsicker L.G., Bain R.P., et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med. 329:(20):1993;1456-1462
103. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. N Engl J Med. 327:(10):1992;669-677
104. Sleight P., Yusuf S., Pogue J., et al. Blood-pressure reduction and cardiovascular risk in HOPE Study. Heart Outcomes Prevention Evaluation (HOPE) Study. Lancet. 358:2001;2130-2131
105. Sorof J.M., Cargo P., Graepel J., et al. Beta-blocker/thiazide combination for treatment of hypertensive children A randomized double-blind, placebo-controlled trial. Pediatr Nephrol. 7:2002;345-350
106. Soffer B., Zhang Z., Miller K., et al. A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension. Am J Hypertens. 16:2003;795-800
107. Rogan J.W., Lyszkiewicz D.A., Blowey D., et al. A randomized prospective crossover trial of amlodipine in pediatric hypertension. Pediatr Nephrol. 14:2000;1083-1087
108. Wells T., Frame V., Soffer B., et al. A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension. J Clin Pharmacol. 42:2002;870-880
109. Trachtman H., Frank R., Mahan J.D., et al. Clinical trial of extended-release felodipine in pediatric essential hypertension. Pediatr Nephrol. 18:2003;548-553
110. Gartenmann A.C., Fossali E., von Vigier R.O., et al. Better renoprotective effect of angiotensin II antagonist compared to dihydropyridine calcium channel blocker in childhood. Kidney Int. 64:2003;1450-1454
111. Sorof J.M., Cardwell G., Franco K., et al. Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension. 39:(4):2002;903-908
112. Sorof J., Hanevold C., Portman R., et al. Left ventricular hypertrophy in hypertensive children A report from the international pediatric hypertension association. Am J Hypertens. 15:2002;31A. ((4 [part 2 of 2]), (abstract)
113. Tracy R.E., Newman W.P. III, Wattigney W.A., et al. Risk factors and atherosclerosis in youth autopsy findings of the Bogalusa Heart Study. Am J Med Sci. 310:(suppl 1):1995;S37-S41